8-K

CRH PUBLIC LTD CO 8-K Report (Mar 8, 2012)

Filed March 8, 2012For Securities:CRH

Summary

This 8-K filing from CRH PUBLIC LTD CO (CRH) on March 8, 2012, primarily concerns disclosures related to director and PDMR (Persons Discharging Managerial Responsibility) shareholdings. The report details transactions executed by Neil Colgan, identified as Secretary & Spouse, in relation to CRH ordinary shares. Specifically, it highlights the exercise of share options and the subsequent sale of shares by Mr. Colgan. Investors should note the specific details of these transactions, including the number of shares acquired and disposed of, and the prices at which these occurred. While this filing doesn't represent a material corporate event like a merger or acquisition, it provides transparency into insider trading activity, which is a key aspect of corporate governance and can offer insights into management's perspective on the company's stock value.

Key Highlights

  • 1Disclosure of share transactions by Neil Colgan, a Person Discharging Managerial Responsibility (PDMR) and Secretary & Spouse.
  • 2Neil Colgan exercised share options, acquiring 8,872 ordinary shares.
  • 3Neil Colgan subsequently sold 8,375 ordinary shares.
  • 4The exercise of options occurred at a price of €11.8573 per share.
  • 5The sale of shares occurred at a price of €15.05 per share.
  • 6All transactions reported took place on March 7, 2012, and were officially notified to the issuer on the same day.
  • 7The filing also provides information on the total percentage of the issued class of shares acquired and disposed of, and the resulting total holding.

Frequently Asked Questions

The primary purpose of this 8-K filing is to report transactions involving the shares of CRH PUBLIC LTD CO by a Person Discharging Managerial Responsibility (PDMR), Neil Colgan. This includes the exercise of share options and the subsequent sale of shares.

Neil Colgan is identified as a PDMR, and also as Secretary & Spouse of the primary PDMR. He exercised share options and sold CRH ordinary shares, as detailed in the filing.

Neil Colgan exercised options to acquire 8,872 ordinary shares at €11.8573 per share. He then sold 8,375 ordinary shares at €15.05 per share.

This filing pertains to individual director/PDMR share transactions and does not, in itself, indicate a change in CRH's overall financial performance or future outlook. It is a regulatory disclosure requirement for transparency regarding insider holdings and transactions.